Long-Term Safety and Tolerability of a New Monthly Extended-Release Formulation of Risperidone (RBP-7000) in the Treatment of Subjects With Schizophrenia

NEUROPSYCHOPHARMACOLOGY(2017)

Cited 0|Views0
No score
Key words
Antipsychotic,Schizophrenia,Extended-Release Depot,Long-Term Safety
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined